- Home
- PCRX vs UHT Comparison
PCRX vs UHT Comparison
Compare PCRX & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- UHT
- Stock Information
- Founded
- PCRX 2006
- UHT 1986
- Country
- PCRX United States
- UHT United States
- Employees
- PCRX N/A
- UHT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- UHT Real Estate Investment Trusts
- Sector
- PCRX Health Care
- UHT Real Estate
- Exchange
- PCRX Nasdaq
- UHT Nasdaq
- Market Cap
- PCRX 1.2B
- UHT N/A
- IPO Year
- PCRX 2011
- UHT N/A
- Fundamental
- Price
- PCRX $26.59
- UHT $39.68
- Analyst Decision
- PCRX Buy
- UHT
- Analyst Count
- PCRX 10
- UHT 0
- Target Price
- PCRX $29.30
- UHT N/A
- AVG Volume (30 Days)
- PCRX 892.8K
- UHT 70.8K
- Earning Date
- PCRX 02-27-2025
- UHT 02-25-2025
- Dividend Yield
- PCRX N/A
- UHT 7.35%
- EPS Growth
- PCRX N/A
- UHT 3.98
- EPS
- PCRX N/A
- UHT 1.31
- Revenue
- PCRX $694,957,000.00
- UHT $99,899,000.00
- Revenue This Year
- PCRX $5.14
- UHT N/A
- Revenue Next Year
- PCRX $2.44
- UHT N/A
- P/E Ratio
- PCRX N/A
- UHT $29.93
- Revenue Growth
- PCRX 4.40
- UHT 3.43
- 52 Week Low
- PCRX $11.16
- UHT $32.27
- 52 Week High
- PCRX $31.67
- UHT $47.30
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- UHT 60.60
- Support Level
- PCRX $25.06
- UHT $38.31
- Resistance Level
- PCRX $27.10
- UHT $39.56
- Average True Range (ATR)
- PCRX 1.45
- UHT 0.94
- MACD
- PCRX 0.28
- UHT 0.31
- Stochastic Oscillator
- PCRX 86.23
- UHT 93.31
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.